 | • レポートコード：TPM-B05147 • 出版社/出版日：Transparency Market Research / 2018年4月18日 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：Pharmaceutical |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、非経口栄養の世界市場について調べ、非経口栄養の世界規模、市場動向、市場環境、栄養物の種類別（炭水化物、非経口脂肪乳剤、単回投与アミノ酸溶液、微量元素、ビタミン・ミネラル）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・非経口栄養の世界市場動向 ・非経口栄養の世界市場環境 ・非経口栄養の世界市場規模 ・非経口栄養の世界市場規模：栄養物の種類別（炭水化物、非経口脂肪乳剤、単回投与アミノ酸溶液、微量元素、ビタミン・ミネラル） ・非経口栄養の世界市場：地域別市場規模・分析 ・非経口栄養の北米市場規模・予測 ・非経口栄養のアメリカ市場規模・予測 ・非経口栄養の中南米市場規模・予測 ・非経口栄養のヨーロッパ市場規模・予測 ・非経口栄養のアジア市場規模・予測 ・非経口栄養の中東市場規模・予測 ・非経口栄養のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Parental Nutrition Market: Overview
Malnutrition poses a great risk to human life. The World Health Organization (WHO) states that malnutrition forms the reason for 11 percent of the diseases prevailing across the world. Moreover, the rising occurrence of malnutrition can lead to the emergence of problems such as food insecurity and political unrest. Therefore, the increasing incidence coupled with the rising concerns is promoting the uptake of parental nutritional.
This report serves with a 360-degree view of the global parental nutrition market by providing insights into all important aspects, including trends and opportunities, nutrient type and regional segmentation, and vendor landscape.
Global Parental Nutrition Market: Drivers and Restraints
The growing incidence of chronic diseases such as ischemic bowel disease, gastrointestinal disorders, diabetes, Crohn’s disease, and cancer is one of the primary growth stimulants of the global market. In addition, the burgeoning count of malnourished children, especially in developing and less developed countries, is escalating the development of the parental nutrition market. Furthermore, the widening base of geriatrics across the globe is also stoking the growth of the market, since aged people are more likely to suffer from the deficiency of several essential nutrients.
On the flip side, the upward rise of the market is marred by the rising health risks incurred due to improper monitoring. Various cases of unexplained gaining of weight, allergic reactions, muscle pain, and shortness of breath have been reported after the uptake of parental nutrition. Furthermore, a study by The American Society for Nutrition states that consistent utilization of parenteral nutrition therapy may lead to metabolic complications and liver diseases.
Global Parental Nutrition Market: Geographical Segmentation
From the geographical standpoint, the report classifies the global parenteral nutrition market into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America will continue to be the frontrunner in the global arena until 2023. The growth of the region can be attributed to the favorable reimbursement scenario. The U.S. and Canada will be key revenue contributors to the region. The expanding pool of patients suffering from cancer and diabetes and growing geriatric population are triggering the adoption of parental nutrition in these countries. Furthermore, the increasing efforts by regional players to expand their operations within Canada is working in favor of the North America parenteral nutrition market.
On the other hand, Asia Pacific is anticipated to be the most promising region, progressing at a noteworthy 7.0% CAGR during the review period. The flourishing growth of the pharmaceutical industry, particularly in countries such as Taiwan, Thailand, Indonesia, Singapore, China, and India, is augmenting the growth of the region. Besides this, the mounting cases of preterm birth, resulting in increased cases of malnutrition is also contributing to the growth of the region.
Global Parental Nutrition Market: Competitive Landscape
The majority of players in the global parental nutrition market are aiming at enhancing their line of products and expanding manufacturing facilities to ensure utmost safety and quality of their offerings. Market participants are also focusing towards entering into strategic joint ventures in order to consolidate their position in the market. Some of the key companies operating in the global parental nutrition market are Baxter International Inc., Fresenius SE & Co. KGaA, Sichuan Kelun Pharmaceutical Co. Ltd., Allergan plc. (Actavis plc.), Grifols S.A., and Pfizer Inc.
Key Segments of the Global Parenteral Nutrition Market
Global Parenteral Nutrition Market, By Type of Nutrient
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins and Minerals
Global Parenteral Nutrition Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Taiwan
South Korea
Rest of APAC
Latin America (LATAM)
Argentina
Mexico
Rest of LATAM
Middle East and Africa (MEA)
Turkey
Rest of MEA
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Parenteral Nutrition Market: Market Snapshot
2.2 Global Parenteral Nutrition Market Revenue, by Type of Nutrient, 2014 (US$ Mn)
2.4 Global Parenteral Nutrition Market Share, by Geography (Value %)
Chapter 3 Global Parenteral Nutrition Market– Industry Analysis
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Driver
3.2.1.1 Increase in incidence of chronic diseases
3.2.1.2 Rise in cases of malnutrition
3.2.1.3 Approvals of novel parenteral nutrition combinations
3.2.1.4 Aging population
3.2.2 Market Restraint
3.2.2.1 Side effects or complications related to parenteral nutrition products
3.2.3 Market Opportunity
3.2.3.1 Expanding footprint in emerging nations that offer sustained growth opportunities
3.3 Porter’s Five Forces Analysis: Global Parenteral Nutrition Market
3.4 Event Impact Analysis: Global Parenteral Nutrition Market
3.5 Market Attractiveness Analysis: Global Parenteral Nutrition Market
3.6 Global Market Share – Parenteral Nutrition Market (2014) (%)
3.6.1 North America Market Share – Parenteral Nutrition Market (2014) (%)
3.6.2 Europe Market Share – Parenteral Nutrition Market (2014) (%)
3.6.3 Asia Pacific Market Share – Parenteral Nutrition Market (2014) (%)
3.6.4 Latin America Market Share – Parenteral Nutrition Market (2014) (%)
3.6.5 Middle East & Africa Market Share – Parenteral Nutrition Market (2014) (%)
3.6.6 Market Share – Carbohydrates Parenteral Nutrition Market (2014) (%)
3.6.7 Market Share – Parenteral Lipid Emulsion Parenteral Nutrition Market (2014) (%)
3.6.8 Market Share – Single Dose Amino Acids Parenteral Nutrition Market (2014) (%)
3.6.9 Market Share – Other Parenteral Nutrition Products Market (2014) (%)
Chapter 4 Market Segmentation – By Type of Nutrient
4.1 Introduction
4.2 Global Parenteral Nutrition Market Revenue, by Types of Nutrient, 2013–2023, (US$ Mn)
4.2.1 Global Carbohydrates Market Revenue, 2013–2023, (US$ Mn)
4.2.2 Global Parenteral Lipid Emulsions Market Revenue, 2013–2023, (US$ Mn)
4.2.3 Global Single Dose Amino Acid Solutions Market Revenue, 2013–2023, (US$ Mn)
4.2.4 Global Trace Elements Market Revenue, 2013–2023, (US$ Mn)
4.2.5 Global Vitamins and Minerals Market Revenue, 2013–2023, (US$ Mn)
Chapter 5 Market Segmentation – By Geography
5.1 Global Parenteral Nutrition Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.2 North America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.3 Europe Parenteral Nutrition Market, by Country, 2013–2023 (US$ Mn)
5.4 Asia Pacific Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.5 Latin America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Middle East & Africa Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
Chapter 6 Recommendations
6.1 Expand presence in developing economies
6.2 Increase in research and development activities
6.3 Long-term contract with hospitals and community care centers
Chapter 7 Company Profiles
7.1 Allergan plc (Actavis plc)
7.2 Baxter International, Inc.
7.3 B. Braun Melsungen AG
7.4 Claris Lifesciences Limited
7.5 Fresenius SE & Co. KGaA
7.6 Grifols S.A.
7.7 Pfizer, Inc. (Hospira, Inc.)
7.8 Sichuan Kelun Pharmaceutical Co., Ltd.